Cartalax 20MG
$65.00
Cartalax 20MG is a 20-milligram format of Cartalax, a short peptide fragment developed in Russian peptide bioregulator research. Researchers study Cartalax in preclinical and exploratory settings related to cartilage biology, extracellular matrix signaling, and connective tissue models. Interest often focuses on how small regulatory peptides may influence gene expression patterns in cell and tissue systems.
In Stock
Cartalax 20MG is a 20-milligram format of Cartalax, a peptide fragment described in peptide bioregulator literature and explored in experimental research involving cartilage and connective tissue biology. Studies have examined Cartalax 20MG in model systems used to investigate chondrocyte activity, extracellular matrix regulation, and tissue signaling pathways, with findings generally interpreted as preliminary and context dependent.
Because Cartalax is discussed as a low molecular weight regulatory peptide, it is often used in laboratory work where researchers compare peptide fragments for their potential to modulate transcriptional responses and cell behavior in culture or ex vivo preparations. Analytical characterization commonly focuses on identity confirmation and composition rather than therapeutic intent.
- Specification: 20MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
CJC-1295 No DAC + Ipamorelin 10MG is a combined 10MG format pairing a CJC 1295 (no DAC) GHRH analogue with ipamorelin, a ghrelin receptor agonist peptide. This blend is commonly used in research that examines pulsatile growth hormone signaling pathways and IGF 1 related biomarkers. Studies have explored these peptides in endocrine and metabolism focused experimental models.
In Stock
CJC 1295 With DAC 5MG is a 5-milligram format of CJC-1295 with drug affinity complex (DAC), a synthetic growth hormone releasing hormone analogue peptide. Researchers study this modified GHRH fragment for its potential to extend peptide half life through albumin binding. Studies have examined CJC 1295 With DAC 5MG in preclinical and investigational settings focused on pulsatile GH signaling and IGF 1 related endpoints.
In Stock
MT1 10Mg 10MG refers to a 10-milligram format of MT1, a melanocortin research peptide commonly associated with melanotropin analog research. Researchers study MT1 in the context of melanocortin receptor signaling, pigmentation pathways, and related neuroendocrine models.
In Stock
Glutathione – 600MG is a 600-milligram format of glutathione, a naturally occurring tripeptide made from glutamate, cysteine, and glycine. Researchers study glutathione in redox biology and oxidative stress models, including work focused on cellular antioxidant systems. It is also used in laboratory assays that examine thiol status and detoxification related pathways.
In Stock
GHK-Cu + TB-500 + BPC-157 + KPV 80MG is an 80-milligram multi-peptide blend combining a copper tripeptide complex with three commonly studied synthetic peptides. Researchers investigate these components in preclinical and in vitro work related to extracellular matrix biology, cell migration signaling, and tissue model recovery. Studies have also examined GHK-Cu, TB-500, BPC-157, and KPV in contexts involving inflammatory signaling pathways and barrier integrity models.
In Stock
SS-31 10MG is a 10-milligram format of SS-31, a synthetic mitochondria targeted tetrapeptide also known as elamipretide. Researchers study SS-31 for its potential interactions with cardiolipin and mitochondrial membrane function in preclinical models. Studies have examined SS-31 in cellular and animal research involving bioenergetics and oxidative stress pathways.
In Stock
GHK-Cu 100MG is a 100-milligram format of GHK-Cu, a copper complex of the tripeptide glycyl L histidyl L lysine. Researchers study this peptide copper complex in models of skin biology, extracellular matrix signaling, and tissue remodeling. Studies have also examined GHK-Cu in the context of wound related research and oxidative stress pathways.
In Stock
MOTS-C 10MG is a 10-milligram format of MOTS-C, a 16 amino acid mitochondria-derived peptide encoded within mitochondrial 12S rRNA. Researchers study MOTS-C in relation to metabolic signaling, cellular stress responses, and mitochondrial nuclear communication in preclinical systems. Its small size and endogenous origin make it a common target in mechanistic peptide research.
In Stock
MT-2 Melanotan II Acetate 10MG is a 10-milligram format of melanotan II, a synthetic melanocortin peptide analogue related to alpha MSH. Researchers study it for its potential interaction with melanocortin receptors and downstream signaling in pigmentation and appetite models. Studies have also examined MT-2 Melanotan II Acetate 10MG in broader neuroendocrine research contexts.
In Stock
BPC-157 + GHK-GHK-Cu + TB-500 70MG is a 70-milligram combination format of three commonly studied research peptides: BPC-157, GHK-Cu, and TB-500. Researchers investigate these peptides in preclinical work involving connective tissue biology, angiogenesis signaling, and recovery related pathways. The blend is used in experimental designs where multiple peptide classes are evaluated together under controlled laboratory conditions.
In Stock
NAD 1000MG is a 1000-milligram format of nicotinamide adenine dinucleotide, a ubiquitous pyridine nucleotide cofactor central to cellular redox chemistry. Researchers study NAD in relation to mitochondrial metabolism, energy transfer reactions, and NAD dependent signaling pathways.
In Stock
SS-31 50MG is a 50-milligram format of SS-31, a synthetic tetrapeptide also known as elamipretide. Researchers study SS-31 for its potential to localize to mitochondria and for its use in preclinical models examining mitochondrial membrane and bioenergetic pathways.
In Stock
